{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:35:55Z","timestamp":1791848155333,"version":"4.3.4"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T00:00:00Z","timestamp":1174348800000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Skinmed"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:p> <jats:italic>\n            <jats:bold>Objective.<\/jats:bold> To compare the safety and efficacy of doxepin and hydroxyzine in the treatment of chronic pruritus due to exposure to sulfur mustard.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Methods.<\/jats:bold> In a randomized, double\u2010blind safety and efficacy study, 50 patients with chronic pruritus were given either doxepin 10 mg\/d or hydroxyzine 25 mg\/d for 4 weeks. Pruritic score was calculated for each patient before treatment and 1 month after.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Results.<\/jats:bold> After treatment, the mean pruritic scores \u00b1 SD of the hydroxyzine and doxepin groups were 16.7\u00b12.3 and 17.8\u00b12.5, respectively. The severity of pruritus was decreased in 80% of patients in the hydroxyzine group and 75% in the doxepin group (<\/jats:italic>P<jats:italic>=.786). Eighteen patients in the hydroxyzine group and 14 patients in the doxepin group reported sedation.<\/jats:italic><\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Conclusions.<\/jats:bold>Both hydroxyzine and doxepin are effective and have equivalent results in controlling the symptoms of patients with chronic pruritus due to exposure to sulfur mustard.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1540-9740.2007.05880.x","type":"journal-article","created":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T15:17:01Z","timestamp":1174403821000},"page":"70-72","source":"Crossref","is-referenced-by-count":21,"title":["Comparison of Hydroxyzine and Doxepin in Treatment of Pruritus Due to Sulfur Mustard"],"prefix":"10.1111","volume":"6","author":[{"given":"Majid","family":"Shohrati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Amini","family":"Harandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Masoud","family":"Davoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Almasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,3,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-8343(97)00155-2"},{"key":"e_1_2_6_3_2","first-page":"96","article-title":"Quality of life in patients with urticaria","volume":"27","author":"Weldon DR","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07050.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.04.079"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-005-1202-x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP59124"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(79)80094-8"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2005.032540"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jom.0000094993.20914.d1"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2005.06.014"},{"key":"e_1_2_6_12_2","first-page":"S1","article-title":"Clinical management of mustard gas casualties","volume":"3","author":"Willems JL","year":"1989","journal-title":"Ann Med Mil Belg"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(00)00060-0"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2005.00364.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archderm.1992.01680160059004","article-title":"Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas","volume":"128","author":"Momeni AZ","year":"1992","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1996.0324"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200322020-00006"},{"key":"e_1_2_6_18_2","first-page":"717","article-title":"A topical skin protectant against chemical warfare agents","volume":"5","author":"Kadar T","year":"2003","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.15110"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000044967"},{"key":"e_1_2_6_21_2","first-page":"17","article-title":"Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis","volume":"14","author":"Monroe EW","year":"1992","journal-title":"Clin Ther"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra033121"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80246-5"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05293.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.12.1522"},{"key":"e_1_2_6_26_2","first-page":"396","article-title":"High dose cetirizine: a case report","volume":"71","author":"Nordness M","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.002"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(95)70173-7"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.2002.01047.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/jpet.105.097014","article-title":"Microarray analysis of mouse ear tissue exposed to bis\u2010(2\u2010chloroethyl) sulfide: gene expression profiles correlate with treatment efficacy and an established clinical endpoint","volume":"317","author":"JF III","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1044"}],"container-title":["SKINmed: Dermatology for the Clinician"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-9740.2007.05880.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-9740.2007.05880.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T19:29:53Z","timestamp":1696966193000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-9740.2007.05880.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1111\/j.1540-9740.2007.05880.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-9740.2007.05880.x","archive":["Portico"],"relation":{},"ISSN":["1540-9740","1751-7125"],"issn-type":[{"value":"1540-9740","type":"print"},{"value":"1751-7125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}